Skip to main content

Advertisement

Log in

Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Aims

Evidence of a role for type 2 diabetes in overall cancer risk and risk for specific types of cancer is limited in ethnic Chinese populations. We therefore investigated whether there is an association between diabetes and cancer incidence in Taiwan.

Methods

This study recruited a total of 3602 adults aged 35 years or over (average 54.9 ± 12.3 years, 52.8% women). Participants with fasting glucose ≥126 mg/dL, or taking hypoglycemic medications, were classed as having type 2 diabetes. Cancer incidence was established through regular follow-up interviews and medical records. Cox proportional hazard regression models were used to examine associations for diabetes with risk of all-cause and site-specific cancers.

Results

During a median of follow-up of 10.5 years, 275 individuals developed cancer, including 157 digestive cancers and 31 urinary cancers. Younger participants (aged < 55 years) with diabetes had a greater risk of all cancers [adjusted relative risk (RR) 3.42; 95% confidence interval (CI), 1.78–6.57], digestive cancers (adjusted RR 2.88; 95% CI 1.15–6.94) and urinary cancers (adjusted RR 13.4; 95% CI 2.70–66.3) compared with individuals in the same age group without diabetes.

Conclusions

Our results clearly demonstrate that middle-aged individuals of Chinese ethnicity with diabetes have a greater risk of all-cause cancer and specific subtypes of cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. American Cancer Society (2015) Global cancer facts and figures, 3rd edn. American Cancer Society, Atlanta

    Google Scholar 

  2. Shikata K, Ninomiya T, Kiyohara Y (2013) Diabetes mellitus and cancer risk: review of the epidemiological evidence. Cancer Sci 104:9–14

    Article  CAS  PubMed  Google Scholar 

  3. Wong KC, Wang Z (2006) Prevalence of type 2 diabetes mellitus of Chinese populations in Mainland China, Hong Kong, and Taiwan. Diabetes Res Clin Pract 73:126–134

    Article  PubMed  Google Scholar 

  4. Barone BB, Yeh HC, Snyder CF et al (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L (2014) Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 25:329–338

    Article  PubMed  Google Scholar 

  6. Chaudhry ZW, Hall E, Kalyani RR, Cosgrove DP, Yeh HC (2013) Diabetes and pancreatic cancer. Curr Probl Cancer 37:287–292

    Article  PubMed  Google Scholar 

  7. Fang H, Yao B, Yan Y et al (2013) Diabetes mellitus increases the risk of bladder cancer: an updated meta-analysis of observational studies. Diabetes Technol Ther 15:914–922

    Article  PubMed  PubMed Central  Google Scholar 

  8. Giovannucci E (2001) Insulin, insulin-like growth factors and colon cancer: a review of the evidence. Nutr Sci 131:3109S–3120S

    CAS  Google Scholar 

  9. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60:207–221

    Article  PubMed  Google Scholar 

  10. Nakamura K, Wada K, Tamai Y et al (2013) Diabetes mellitus and risk of cancer in Takayama: a population-based prospective cohort study in Japan. Cancer Sci 104:1362–1367

    Article  CAS  PubMed  Google Scholar 

  11. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM (2005) Fasting serum glucose level and cancer risk in Korean men and women. JAMA 293:194–202

    Article  CAS  PubMed  Google Scholar 

  12. Tseng CH (2013) Higher risk of mortality from lung cancer in Taiwanese people with diabetes. Diabetes Res Clin Pract 102:193–201

    Article  PubMed  Google Scholar 

  13. Lee YTSFC, Yang CY, Chien KL et al (2000) Chin-Shan community cardiovascular cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol 53:836–846

    Google Scholar 

  14. Chien KL, Hsu HC, Sung FC, Su TC, Chen MF, Lee YT (2005) Hyperuricemia as a risk factor on cardiovascular events in Taiwan: the Chin-Shan community cardiovascular cohort study. Atherosclerosis 183:147–155

    Article  CAS  PubMed  Google Scholar 

  15. Saito E, Charvat H, Goto A et al (2016) Burden of cancer associated with type 2 diabetes mellitus in Japan, 2010–2030. Cancer Sci 107:521–527

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Kevin D, Burroughs SED, Carl Barrett J, Taylor Jack A (1999) Insulin-like growth factor-I: A key regulator of human cancer risk? J Natl Cancer Inst 91:579–581

    Article  Google Scholar 

  17. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R (2009) Diabetes and cancer. Endocr Relat Cancer 16:1103–1123

    Article  CAS  PubMed  Google Scholar 

  18. Tseng CH, Tseng CP, Chong CK et al (2006) Increasing incidence of diagnosed type 2 diabetes in Taiwan: analysis of data from a national cohort. Diabetologia 49:1755–1760

    Article  PubMed  Google Scholar 

  19. Chang CH, Shau WY, Jiang YD et al (2010) Type 2 diabetes prevalence and incidence among adults in Taiwan during 1999–2004: a national health insurance data set study. Diabet Med 27:636–643

    Article  CAS  PubMed  Google Scholar 

  20. Wang M, Hu RY, Wu HB et al (2015) Cancer risk among patients with type 2 diabetes mellitus: a population-based prospective study in China. Sci Rep 5:11503

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Yang X, So WY, Ma RC et al (2009) Low LDL cholesterol, albuminuria, and statins for the risk of cancer in type 2 diabetes: the Hong Kong diabetes registry. Diabetes Care 32:1826–1832

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Yang X, Lee HM, Chan JC (2015) Drug-subphenotype interactions for cancer in type 2 diabetes mellitus. Nat Rev Endocrinol 11:372–379

    Article  CAS  PubMed  Google Scholar 

  23. Chan JC, Malik V, Jia W et al (2009) Diabetes in Asia epidemiology, risk factors, and pathophysiology. JAMA 301:2129–2140

    Article  CAS  PubMed  Google Scholar 

  24. Lo SF, Chang SN, Muo CH et al (2013) Modest increase in risk of specific types of cancer types in type 2 diabetes mellitus patients. Int J Cancer 132:182–188

    Article  CAS  PubMed  Google Scholar 

  25. Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33:1674–1685

    Article  PubMed  PubMed Central  Google Scholar 

  26. Golozar A, Liu S, Lin JA, Peairs K, Yeh HC (2016) Does metformin reduce cancer risks? Methodologic considerations. Curr Diabetes Rep 16:4

    Article  Google Scholar 

  27. Suissa S, Azoulay L (2014) Metformin and cancer: mounting evidence against an association. Diabetes Care 37:1786–1788

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The study was supported by the Ministry of Science and Technology, Taiwan (MOST 103-2314-B-002 -135 -MY3, NSC 102-2314-B-002 -080 -MY2 and NSC 100-2314-B-002 -113 -MY3).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kuo-Liong Chien.

Ethics declarations

Conflict of interest

The authors declared no potential conflicts of interest in this study.

Ethical standard

The study was approved by the Institute Review Board committee of the National Taiwan University Hospital.

Human and animal rights

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008.

Informed consent

Informed consent was obtained from all subjects for being included in this study, which was governed by National Taiwan University Hospital.

Additional information

Managed by Massimo Federici.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 24 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, WS., Chen, PC., Lin, HJ. et al. Association between type 2 diabetes and cancer incidence in Taiwan: data from a prospective community-based cohort study. Acta Diabetol 54, 455–461 (2017). https://doi.org/10.1007/s00592-017-0966-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-017-0966-1

Keywords

Navigation